InsiderTrades

Form 4 for CVX Chevron Corporation

Accepted 2026-08-19 17:23:03 ET · period of report 2026-08-17 · accession 0000093410-26-000175 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-08-19 17:23 2026-08-17 CVX Walz Andrew Benjamin Pres, DM, C M - OptEx $121.83 +16.8K 16.8K +120,000% +$2.05M
D 2026-08-19 17:23 2026-08-17 CVX Walz Andrew Benjamin Pres, DM, C S - Sale+OE $201.06 -16.8K 14 -100% -$3.38M
DM 2026-08-19 17:23 2026-08-17 CVX Walz Andrew Benjamin Pres, DM, C M - OptEx $0.00 -16.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-17 M A 4,100 $88.20 4,114 D — — (F1) This number includes the acquisition of stock resulting from the reinvestment of dividends on vested restricted stock units (14 shares) under the Chevron Corporation 2022 Long-Term Incentive Plan.
2 Common Common Stock 2026-08-17 M A 12,700 $132.69 16,814 D — —
3 Common Common Stock 2026-08-17 S D 16,800 $201.06 14 D — — (F2) This transaction was executed in multiple trades at prices ranging from $201.01 to $201.1150. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
4 Derivative Non-Qualified Stock Option (Right to Buy) 2026-08-17 M D 4,100 $0.00 0 D $88.20 · — to 2031-01-27 4,100 Common Stock (F4) Option granted 1/27/2021. One-third of the shares subject to the option vested on January 31, 2022, January 31, 2023 and January 31, 2024, respectively.
5 Derivative Non-Qualified Stock Option (Right to Buy) 2026-08-17 M D 12,700 $0.00 0 D $132.69 · — to 2032-01-26 12,700 Common Stock (F5) Option granted 1/26/2022. One-third of the shares subject to the option vested on January 31, 2023, January 31, 2024 and January 31, 2025, respectively.